Here are some important highlights from the meeting.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
 

 

New Research on Mechanisms in the Development of PF
Launched: November 12, 2017

 

Exploring New Therapeutic Avenues for Managing PF
Launched: November 12, 2017

 

— Dr. Sonye K. Danoff

— Dr. Sonye K. Danoff

 


New Approaches to the Diagnosis of IPF
Launched: November 12, 2017

 

Updates on Registry Enrollment and Growth of the Care Center Network
Launched: November 12, 2017

 

— Dr. Timothy P. Whelan

— Dr. Timothy P. Whelan

 


Exploring the Basic Mechanisms that Contribute to Development of Lung
Fibrosis

Launched: November 12, 2017

 

— Dr. Sonye K. Danoff
— Dr. Timothy P. Whelan

Gene Abnormalities and ILD
Launched: November 12, 2017

 

 

— Dr. Sonye K. Danoff
— Dr. Timothy P. Whelan

 


Environmental Influences on the Development of Pulmonary Fibrosis
Launched: November 12, 2017

 

Genetics and Personalized Medicine for Patients with Pulmonary Fibrosis
Launched: November 12, 2017

 

— Dr. Sonye K. Danoff
— Dr. Timothy P. Whelan

— Dr. Sonye K. Danoff
— Dr. Timothy P. Whelan

 

 

Access other Therapeutic Areas: